Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewBX 471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1). Exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4. Inhibits MIP-α/CCL3-induced intracellular Ca2+ mobilization. Orally active; effectively reduces disease severity in a rat model of multiple sclerosis. Decreases renal fibrosis in a mouse model of obstructive nephropathy.
BX 471 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.
M. Wt | 434.89 |
Formula | C21H24ClFN4O3 |
Storage | Store at +4°C |
Purity | ≥98% (HPLC) |
CAS Number | 217645-70-0 |
PubChem ID | 512282 |
InChI Key | XQYASZNUFDVMFH-CQSZACIVSA-N |
Smiles | FC1=CC=C(CN2C[C@@H](C)N(C(COC3=CC=C(Cl)C=C3NC(N)=O)=O)CC2)C=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 43.49 | 100 | |
ethanol | 21.74 | 50 |
The following data is based on the product molecular weight 434.89. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.3 mL | 11.5 mL | 22.99 mL |
5 mM | 0.46 mL | 2.3 mL | 4.6 mL |
10 mM | 0.23 mL | 1.15 mL | 2.3 mL |
50 mM | 0.05 mL | 0.23 mL | 0.46 mL |
References are publications that support the biological activity of the product.
Liang (2000) Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J.Biol.Chem. 275 19000 PMID: 10748002
Anders (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J.Clin.Invest. 109 251 PMID: 11805137
Furuichi et al (2008) Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J.Immunol. 181 8670 PMID: 19050287
If you know of a relevant reference for BX 471, please let us know.
Keywords: BX 471, BX 471 supplier, selective, chemokine, receptor, antagonists, CCR1, BX471, multiple, sclerosis, renal, fibrosis, leukocyte, recruitment, Rantes, ZK-811752, Chemokine, CC, Receptors, 3496, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for BX 471. Do you know of a great paper that uses BX 471 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review BX 471 and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.